Myocardial contractility after in Vitro treatment with class III antiarrhythmic drug Nibentan

In Vitro Treatment

Effects of EGIS-7229 (S 21407), a Novel Class III Antiarrhythmic Drug, on Myocardial Refractoriness to Electrical Stimulation In Vivo and In Vitro

Journal of Cardiovascular Pharmacology ◽

10.1097/00005344-200101000-00009 ◽

2001 ◽

Vol 37 (1) ◽

pp. 78-88 ◽

Cited By ~ 5

Author(s):

Anikó Kovács ◽

Ildikó Gyönös ◽

János Magyar ◽

Tamás Bányász ◽

Péter P. Nánási ◽

...

Keyword(s):

Electrical Stimulation ◽

Antiarrhythmic Drug ◽

Class Iii ◽

Analysis of Arrhythmogenic Profile in a Canine Model of Chronic Atrioventricular Block by Comparing In Vitro Effects of the Class III Antiarrhythmic Drug Nifekalant on the Ventricular Action Potential Indices Between Normal Heart and Atrioventricular Block Heart

Journal of Pharmacological Sciences ◽

10.1254/jphs.fp0061077 ◽

2007 ◽

Vol 103 (2) ◽

pp. 181-188 ◽

Cited By ~ 13

Author(s):

Akira Takahara ◽

Hideki Nakamura ◽

Hideaki Nouchi ◽

Takeshi Tamura ◽

Toshikazu Tanaka ◽

...

Keyword(s):

Action Potential ◽

Atrioventricular Block ◽

Antiarrhythmic Drug ◽

Canine Model ◽

Class Iii ◽

Normal Heart ◽

In Vitro Effects ◽

Ventricular Action Potential

Effects of the New Class III Antiarrhythmic Drug E-4031 on Myocardial Contractility and Electrophysiological Parameters

Journal of Cardiovascular Pharmacology ◽

10.1097/00005344-199103000-00018 ◽

1991 ◽

Vol 17 (3) ◽

pp. 480-487 ◽

Cited By ~ 64

Author(s):

Erich Wettwer ◽

Günter Scholtysik ◽

Andreas Schaad ◽

Herbert Himmel ◽

Ursula Ravens

Keyword(s):

Antiarrhythmic Drug ◽

Myocardial Contractility ◽

Class Iii ◽

New Class ◽

Dofetilide, a New Class III Antiarrhythmic Drug Reduces Hospital Admissions for Congestive Heart Failure - Secondary Endpoints of the DIAMOND-CHF Study

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(97)83859-4 ◽

1998 ◽

Vol 31 (2) ◽

pp. 33A ◽

Cited By ~ 3

Author(s):

L Kaber

Keyword(s):

Heart Failure ◽

Congestive Heart Failure ◽

Antiarrhythmic Drug ◽

Hospital Admissions ◽

Class Iii ◽

New Class ◽

Secondary Endpoints

Effects of the New Class-III Antiarrhythmic Drug D-Sotalol on Contractile Function of Postischemic Myocardium

Journal of Cardiovascular Pharmacology ◽

10.1097/00005344-199104000-00009 ◽

1991 ◽

Vol 17 (4) ◽

pp. 581-586 ◽

Cited By ~ 7

Author(s):

Hans Martin Hoffineister ◽

Susanne Müller ◽

Ludger Scipel

Keyword(s):

Antiarrhythmic Drug ◽

Contractile Function ◽

Class Iii ◽

New Class ◽

Postischemic Myocardium

Influence of dronedarone (a class III antiarrhythmic drug) on the anticonvulsant potency of four classical antiepileptic drugs in the tonic–clonic seizure model in mice

Journal of Neural Transmission ◽

10.1007/s00702-018-1940-y ◽

2018 ◽

Vol 126 (2) ◽

pp. 115-122 ◽

Cited By ~ 1

Author(s):

Katarzyna M. Sawicka ◽

Agnieszka Wawryniuk ◽

Jadwiga Daniluk ◽

Sławomir Karwan ◽

Magdalena Florek-Łuszczki ◽

...

Keyword(s):

Antiepileptic Drugs ◽

Antiarrhythmic Drug ◽

Clonic Seizure ◽

Tonic Clonic Seizure ◽

Class Iii ◽

Seizure Model

Effects of Azimilide, a New Class III Antiarrhythmic Drug, on Reentrant Circuits Causing Ventricular Tachycardia and Fibrillation in a Canine Model of Myocardial Infarction

Journal of Cardiovascular Electrophysiology ◽

10.1046/j.1540-8167.2001.01025.x ◽

2001 ◽

Vol 12 (9) ◽

pp. 1025-1033 ◽

Cited By ~ 4

Author(s):

HEIKO SCHMITT ◽

CANDIDO CABO ◽

JAMES C. COROMILAS ◽

ANDREW L. WIT

Keyword(s):

Myocardial Infarction ◽

Ventricular Tachycardia ◽

Antiarrhythmic Drug ◽

Canine Model ◽

Class Iii ◽

New Class ◽

Ventricular Tachycardia And Fibrillation

Electrophysiologic Effects of the New Class III Antiarrhythmic Drug Dofetilide Compared to the Class IA Antiarrhythmic Drug Quinidine in Experimental Canine Atrial Flutter:.

Journal of Cardiovascular Electrophysiology ◽

10.1111/j.1540-8167.1996.tb00594.x ◽

1996 ◽

Vol 7 (9) ◽

pp. 809-827 ◽

Cited By ~ 29

Author(s):

YONGMEI CHA ◽

ALAN WALES ◽

PAUL WOLF ◽

SHAHIN SHAHROKNI ◽

NEIL SAWHNEY ◽

...

Keyword(s):

Atrial Flutter ◽

Antiarrhythmic Drug ◽

Class Iii ◽

New Class ◽

Experimental Canine

Pharmacological and clinical profile of nifekalant (shinbit injection), a class III antiarrhythmic drug.

Folia Pharmacologica Japonica ◽

10.1254/fpj.119.103 ◽

2002 ◽

Vol 119 (2) ◽

pp. 103-109 ◽

Cited By ~ 8

Author(s):

Akihiro OYABE ◽

Hidetoshi SANO

Keyword(s):

Antiarrhythmic Drug ◽

Clinical Profile ◽

Class Iii ◽

Atrial flutter can be terminated by a class III antiarrhythmic drug but not by a class IC drug

European Heart Journal ◽

10.1093/oxfordjournals.eurheartj.a060402 ◽

1994 ◽

Vol 15 (10) ◽

pp. 1403-1408 ◽

Cited By ~ 36

Author(s):

H. J. G. M. CRIJNS ◽

I. C. VAN GELDER ◽

J. H. KINGMA ◽

P. H. J. M. DUNSELMAN ◽

A. T. M. GOSSELINK ◽

...

Keyword(s):

Atrial Flutter ◽

Antiarrhythmic Drug ◽

Class Iii ◽